ArticleCancers2025

Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.

Gentry G King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.